抗体名 ：CD133抗体
浓度 ：1 mg/ml
是否单克隆 ：多克隆
抗体英文名 ：CD133 antibody
库存 ：大量
宿主 ：兔
供应商 ：上海研卉生物科技有限公司
抗原来源 ：其它
应用范围 ：WB,IHC-P,IF/ICC,P-ELISA
适应物种 ：Human,Mouse,Rat
规格 ：100 μg
CD133抗体
CD133 antibody
Rabbit polyclonal antibody to CD133, which is also known as prominin or AC133. CD133 is a marker frequently found on multipotent progenitor cells, including immature hematopoietic stem and progenitor cells. The protein has been extensively used as a stem cell marker for normal and cancerous tissues.
产品信息
| Category |
Primary antibodies |
| Product name |
CD133 antibody |
| Catalog Number |
orb99113 |
| Host |
Rabbit |
| Clonality |
Polyclonal |
| Tested applications |
WB,IHC-P,IF/ICC,P-ELISA |
| Reacts with |
Human,Mouse,Rat |
| Conjugation |
Unconjugated |
| Target |
CD133 |
| Alternative names |
|
| Form |
10 mM PBS, 0.02% sodium azide, 10 mg/ml BSA |
| Concentration |
- 100 μg (in 100 μl): 1 mg/ml
- 200 μg (in 200 μl): 1 mg/ml |
| Purity |
Polyclonal antibodies are purified by peptide affinity chromatography |
| Isotype |
IgG |
| UniProt ID |
O43490 (Human); O54990 (Mouse) |
| NCBI |
NP_001139319.11; NM_001145847.11 |
| Entrez |
8842 |
| MW |
95 kDa |
| Application notes |
Several IHC experiments have been done on human cancer tissue. Please review the information on the product page under "Additional Information" |
| Dilution range |
IHC-P:1:200, WB: 1:500, IF/ICC: 1:200 |
| Kits Components |
KLH conjugated synthetic peptide derived from human CD133. Please contact us for the exact immunogen sequence. The peptide is available as orb374954. |
| Storage |
After reconstitution store at 4°C.for up to two weeks. For long term storage, aliquot and store at -20°C. Avoid freeze/thaw cycles. |
| PubMed |
25421411; 26028817 |
| References |
1. Endothelial progenitor cells proliferated via MEK-dependent p42 MAPK signaling pathway.
2. Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3'-methyl-4 dimethylaminoazobenzene in rats.
3. Isolation and phenotypic characterization of cancer stem-like side population cells in colon cancer.
4. Influence of interferon-a on the expression of the cancer stem cell markers in pancreatic carcinoma cells.
5. CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy
6. Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme.
7. An innovative three-dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior.
8. Correlation of altered expression of the autophagy marker LC3B with poor prognosis in astrocytoma.
9. Nrf2 Is Involved in Maintaining Hepatocyte Identity during Liver Regeneration.
10.Descriptive analysis of tumor cells with stem like phenotypes in metastatic and benign adrenal tumors.
11. Restoration of erectile function with intracavernous injections of endothelial progenitor cells after bilateral cavernous nerve injury in rats.
12. Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis.
13. Circulating Tumor Cell Composition in Renal Cell Carcinoma.
14.CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer. |
| Note |
For research use only. |
